Tag: Pharma
MaaT Pharma: increase in resources to the liquidity contract
A.S. Published on 09/10/2023 at 10:09 p.m. Photo credit © Maat Pharma (Boursier.com) — MaaT Pharma…
Abionyx Pharma: capital increase completed
(CercleFinance.com) – Abionyx Pharma announces that it has carried out a capital increase of around three million euros (bonus included) for the benefit of categories of people, intended to strengthen…
Medesis Pharma: opening of a safeguard procedure – 03/10/2023 at 6:29 p.m.
(AOF) – Medesis Pharma announces receipt of the judgment of the Montpellier Commercial Court granting it the opening, on September 29, 2023, of a safeguard procedure. This biotech developing drug…
MaaT Pharma announces poster presentation at the 38th annual conference of the Society for Immunotherapy of Cancer (SITC) – 09/27/2023 at 6:17 p.m.
Lyon, France, September 27, 2023 – 6:00 p.m. CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), an advanced clinical-stage biotechnology company, leader in the development of Microbiome Ecosystem TherapiesTM…
MaaT Pharma publishes its 2023 half-year results and provides an update on its activities – 09/26/2023 at 6:15 p.m.
MaaT Pharma publishes its 2023 half-year results and provides an update on its activities: • The ARES study on MaaT013 has reached the threshold of patients required to schedule the…
Maat Pharma: cash flow of 35.1 million euros – 09/26/2023 at 6:17 p.m.
(AOF) – Maat Pharma announces that as of June 30, 2023, its total cash and cash equivalents amounted to 35.1 million euros, compared to 35.2 million euros as of December…
Maat Pharma: cash of 35.1 million euros
(AOF) – Maat Pharma announces that as of June 30, 2023, its total cash and cash equivalents amounted to 35.1 million euros, compared to 35.2 million euros as of December…
ABIONYX Pharma announces its financial results for the first half of 2023 – 09/26/2023 at 8:00 p.m.
Toulouse, FRANCE, Lakeland, UNITED STATES, September 26, 2023, 8:00 p.m. CEST – ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), new generation biotechnology company dedicated to the discovery and…
Inventiva and Hepalys Pharma, Inc., sign an exclusive license agreement to develop and commercialize lanifibranor in Japan and South Korea – 09/20/2023 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), Tokyo (Japan), September 20, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in clinical development…
Oncology: Maat Pharma announces the end of the construction of its Isère factory
(AOF) – MaaT Pharma has announced the end of the construction of a factory dedicated to microbiota-based medicines, in Saint-Quentin-Fallavier in Isère. The biotech, specialist in the development of microbiotherapies…
Innate Pharma: profit down, but cash flow ‘solid’
(CercleFinance.com) – Innate Pharma announced on Thursday a drop in its profit over the first six months of the year, the biotechnology company having suffered from the decline in revenues…
World Sepsis Day: ABIONYX Pharma confirms its commitment against sepsis, a global public health issue – 09/12/2023 at 8:00 p.m.
• Sepsis, 3rd cause of death in the world, worsened by the spread of bacterial infections with global warming and by the aging of the population • No effective therapeutic…